1099.HK 財務： Sinopharm Group Co. Ltd. AI 分析

Q: 技術分析指標如何適用於 1099.HK？

根據技術分析，Sinopharm Group Co. Ltd. 的綜合信號為 Buy。Sinopharm Group Co. Ltd. 有 3 個買入信號，2 個中性信號和 2 個賣出信號。

Q: 1099.HK 的費波那契回檔水準是多少？

Sinopharm Group Co. Ltd. 的費波那契回檔水準是 介於 61.8% 和 78.6% 之間。

Q: Sinopharm Group Co. Ltd. 的 RSI 是多少？

Sinopharm Group Co. Ltd. 的 RSI 目前為 55.36，表明處於 中立 狀態

Q: Sinopharm Group Co. Ltd. 接下來 12 個月的價格是多少？

Sinopharm Group Co. Ltd. 1099.HK 接下來 12 個月的價格預估為 $22.74。

Q: Sinopharm Group Co. Ltd. 預計會漲到多高？

據華爾街分析師稱，Sinopharm Group Co. Ltd. 預計將達到 $25.93 的高預測值。

首頁

股票

1099.HK

預測

SINOPHARM (1099.HK)

Sinopharm Group Co. Ltd.

HK$20.6

0.58%

$0.12

盤中： Jan 20, 15:23:43 HKT

關鍵數據

前收市價

$20.28

開盤價

$20.48

當日範圍

$20.24 - $20.62

52週區間

$16.74 - $21.66

交易量

3.8M

平均成交量

4.4M

每股盈餘 (TTM)

2.43

股息收益率

市值

$27.6B

什麼是 SINOPHARM？

Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. The company is headquartered in Shanghai, Shanghai and currently employs 100,251 full-time employees. The company went IPO on 2009-09-23. The firm operates its business through four segments. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services to domestic and foreign pharmaceutical and health product manufacturers and other suppliers. The Device Distribution segment distributes medical devices to customers. The Pharmaceutical Retail Business segment owns a network of retail pharmacies that are directly operated or franchised. The Other Business segment is engaged in the manufacture and sale of pharmaceuticals, chemical reagents and laboratory supplies.

功能特性

交易策略

資源

市場

Utilizing our sophisticated predictive model, we anticipate notable price fluctuations for 1099.HK in the upcoming periods. Looking toward the future, our 2027 projection indicates an average price target of $22.74. The lowest target is $18.82 and the highest is $25.93. Empower your investment choices with our cutting-edge, data-driven analysis!

1099.HK 股價預測摘要

1099.HK 的頂級分析師評級

根據 23 位分析師對 1099.HK 的股票評級，更新於 Jan 01, 2026

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for 1099.HK. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: 1099.HK is a Buy candidate.

1099.HK stock price ended at $20.44 on 星期二, after rising 0.79%

On the latest trading day Jan 20, 2026, the stock price of 1099.HK rose by 0.79%, climbing from $20.48 to $20.44. Throughout the session, the stock experienced a volatility of 1.28%, with prices fluctuating between a daily low of $20.24 and a high of $20.50. Alongside this price increase, trading volume also rose by 4.4M shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 930.8K shares were traded, amounting to a market value of approximately $27.4B.

1099.HK 技術面訊號

技術面訊號摘要

購買訊號 3

中性訊號 2

賣出訊號 2

Strong Sell

Sell

Neutral

Buy

Strong Buy

1099.HK 目前顯示 3 個買入訊號與 2 個賣出訊號。該股票自 12:00 AM 以來一直處於上升趨勢狀態，在此期間價格總共變動了 0.79%。整體而言，技術指標顯示中期後市趨勢為 Buy。

1099.HK 的看漲／看跌訊號

我們的演算法透過分析移動平均線、RSI、MACD 和成交量等關鍵指標，為1099.HK生成看漲和看跌訊號。這些見解可助您做出明智的投資決策。

後續問題

技術分析指標如何適用於 1099.HK？



1099.HK 的費波那契回檔水準是多少？



Sinopharm Group Co. Ltd. 的 RSI 是多少？



Sinopharm Group Co. Ltd. 接下來 12 個月的價格是多少？



Sinopharm Group Co. Ltd. 預計會漲到多高？



Sinopharm Group Co. Ltd.（1099.HK）價格

1099.HK 股價走勢圖